177 related articles for article (PubMed ID: 22076975)
1. Does one keto group matter? Structure-activity relationships of glycyrrhetinic acid derivatives modified at position C-11.
Csuk R; Schwarz S; Kluge R; Ströhl D
Arch Pharm (Weinheim); 2012 Jan; 345(1):28-32. PubMed ID: 22076975
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of ring A modified glycyrrhetinic acid derivatives.
Csuk R; Schwarz S; Siewert B; Kluge R; Ströhl D
Eur J Med Chem; 2011 Nov; 46(11):5356-69. PubMed ID: 21959232
[TBL] [Abstract][Full Text] [Related]
3. Conversions at C-30 of glycyrrhetinic acid and their impact on antitumor activity.
Csuk R; Schwarz S; Siewert B; Kluge R; Ströhl D
Arch Pharm (Weinheim); 2012 Mar; 345(3):223-30. PubMed ID: 21997717
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
Schwarz S; Csuk R
Bioorg Med Chem; 2010 Nov; 18(21):7458-74. PubMed ID: 20932766
[TBL] [Abstract][Full Text] [Related]
5. Improvement of the cytotoxicity and tumor selectivity of glycyrrhetinic acid by derivatization with bifunctional amino acids.
Csuk R; Schwarz S; Kluge R; Ströhl D
Arch Pharm (Weinheim); 2011 Aug; 344(8):505-13. PubMed ID: 21674592
[TBL] [Abstract][Full Text] [Related]
6. First Occurrence of a Furano-glycyrrhetinoate and Its Cytotoxicity.
Heller L; Sommerwerk S; Tzschöckell F; Wiemann J; Schwarz S; Siewert B; Al-Harrasi A; Csuk R
Arch Pharm (Weinheim); 2015 Dec; 348(12):889-96. PubMed ID: 26548762
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid.
Csuk R; Schwarz S; Kluge R; Ströhl D
Eur J Med Chem; 2010 Dec; 45(12):5718-23. PubMed ID: 20884085
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel heterocyclic ring-fused 18β-glycyrrhetinic acid derivatives with antitumor and antimetastatic activity.
Gao C; Dai FJ; Cui HW; Peng SH; He Y; Wang X; Yi ZF; Qiu WW
Chem Biol Drug Des; 2014 Aug; 84(2):223-33. PubMed ID: 24612785
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Antiproliferative Activity of Novel Heterocyclic Glycyrrhetinic Acid Derivatives.
Alho DPS; Salvador JAR; Cascante M; Marin S
Molecules; 2019 Feb; 24(4):. PubMed ID: 30791593
[TBL] [Abstract][Full Text] [Related]
10. A "natural" approach: synthesis and cytoxicity of monodesmosidic glycyrrhetinic acid glycosides.
Schwarz S; Siewert B; Xavier NM; Jesus AR; Rauter AP; Csuk R
Eur J Med Chem; 2014 Jan; 72():78-83. PubMed ID: 24361520
[TBL] [Abstract][Full Text] [Related]
11. 18β-Glycyrrhetinic acid derivatives induced mitochondrial-mediated apoptosis through reactive oxygen species-mediated p53 activation in NTUB1 cells.
Lin KW; Huang AM; Hour TC; Yang SC; Pu YS; Lin CN
Bioorg Med Chem; 2011 Jul; 19(14):4274-85. PubMed ID: 21696969
[TBL] [Abstract][Full Text] [Related]
12. The synthesis of 18beta-glycyrrhetinic acid derivatives which have increased antiproliferative and apoptotic effects in leukemia cells.
Liu D; Song D; Guo G; Wang R; Lv J; Jing Y; Zhao L
Bioorg Med Chem; 2007 Aug; 15(16):5432-9. PubMed ID: 17566745
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel spin labeled 18β-glycyrrhetinic acid derivatives.
Liu Y; Qian K; Wang CY; Chen CH; Yang X; Lee KH
Bioorg Med Chem Lett; 2012 Dec; 22(24):7530-3. PubMed ID: 23122524
[TBL] [Abstract][Full Text] [Related]
14. 18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines.
Lee CS; Yang JC; Kim YJ; Jang ER; Kim W; Myung SC
Eur J Pharmacol; 2010 Dec; 649(1-3):354-61. PubMed ID: 20868669
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of triazole linked glycosylated 18β-glycyrrhetinic acid derivatives as anticancer agents.
Parida PK; Sau A; Ghosh T; Jana K; Biswas K; Raha S; Misra AK
Bioorg Med Chem Lett; 2014 Aug; 24(16):3865-8. PubMed ID: 25027936
[TBL] [Abstract][Full Text] [Related]
16. N-(2-{3-[3,5-bis(trifluoromethyl)phenyl]ureido}ethyl)-glycyrrhetinamide (6b): a novel anticancer glycyrrhetinic acid derivative that targets the proteasome and displays anti-kinase activity.
Lallemand B; Chaix F; Bury M; Bruyère C; Ghostin J; Becker JP; Delporte C; Gelbcke M; Mathieu V; Dubois J; Prévost M; Jabin I; Kiss R
J Med Chem; 2011 Oct; 54(19):6501-13. PubMed ID: 21888390
[TBL] [Abstract][Full Text] [Related]
17. 18beta-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity.
Lee CS; Kim YJ; Lee MS; Han ES; Lee SJ
Life Sci; 2008 Sep; 83(13-14):481-9. PubMed ID: 18721818
[TBL] [Abstract][Full Text] [Related]
18. Design and Synthesis of New Anticancer Glycyrrhetinic Acids and Oleanolic Acids.
Wang R; Zheng QX; Wang W; Feng L; Li HJ; Huai QY
Biol Pharm Bull; 2017; 40(5):703-710. PubMed ID: 28458357
[TBL] [Abstract][Full Text] [Related]
19. A bioassay-driven discovery of an unexpected selenophene and its cytotoxicity.
Csuk R; Siewert B; Wiemann J
Bioorg Med Chem Lett; 2013 Jun; 23(12):3542-6. PubMed ID: 23664875
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticancer activity of Indolin-2-one derivatives bearing the 4-thiazolidinone moiety.
Wang S; Zhao Y; Zhu W; Liu Y; Guo K; Gong P
Arch Pharm (Weinheim); 2012 Jan; 345(1):73-80. PubMed ID: 21932254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]